Class 562/576 - Beta alanine per se or salt thereof

Subclass of Class 562 - Organic compounds -- part of the class 532-570 series
Definition: The compound which is beta alanine (see structure below)
No. of patents: 32
Last issue date: 06/07/2011

Number	Title	Issue Date
7956218	Organic salts of β-alanine The present invention relates to stable salts of β-alanine and an organic acid endowed with enhanced nutritional and/or therapeutical efficacy in respect to their individual effects and to solid compositions containing such salts, particularly suited to oral admini...	06/07/2011
7268164	Anti-epileptogenic agents Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent ictogenesis and epileptogenesis. Methods for preparing the compounds of the invention are also d...	09/11/2007
7071350	Method of introducing amino group and method of synthesizing amino acid compound The present invention relates to a method for introducing an amino group into an organic acid or an organic ester by reacting an organic salt or an organic ester and ammonia under high-temperature and high-pressure water conditions, a method for synthesizing an amin...	07/04/2006
6790989	Inhibitors of the ICE/ced-3 family of cysteine proteases This invention is directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds having the following structure: wherein A, B, R, R1, R1′ p and q are as defined herein. The invention is a...	09/14/2004
6733985	Preparation of stable liquid and dried synthetic prothrombin time reagents A reagent for determining prothrombin time (PT) including a recombinant protein tissue factor, a mixture of synthetic phospholipids, and a beta, gamma, or delta amino acid stabilizing compound is described for monitoring extrinsic blood coagulation activities. The s...	05/11/2004
6696611	Chemical methods The present invention provides a method for enantioselectively reducing a prochiral carbon centered radical having one or more electron donator groups attached directly to the central prochiral carbon atom of the radical, and/or attached to a carbon atom ...	02/24/2004
6515173	Inhibitors of the ICE/ced-3 family of cysteine proteases This invention s directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds having the following structure: ##STR1## wherein A, B, R, R1, p and q are as defined herein. The invention s all directed to pharmaceutical compositions co...	02/04/2003
6420600	Phenylalaninol derivatives It has been discovered that compounds of the formula: ##STR1## and the pharmaceutically acceptable salts and esters thereof wherein X and Y are as defined below, are more readily absorbed and more bioavailable than the corresponding carboxylic acids from ...	07/16/2002
6407065	VLA-4 antagonists Compounds of the formula I ##STR1## as defined, and their pharmaceutically acceptable salts are VLA-4 antagonists which are useful in inhibiting cell adhesion and in the therapeutic or prophylactic treatment of inflammatory and autoimmune diseases, p...	06/18/2002
6395923	Nitriloxy derivatives of (R) and (S)-carnitine Carnitine derivatives of formula (I) are described in racemic and/or optically active form, as well as the process for their preparation and their use as pharmaceutical anti-angina active ingredients for the treatment of ischaemic heart disease. ##ST...	05/28/2002
6380429	Preparation of sulfonyl imine compounds Disclosed is a process for the oxidation of sulfonamides to sulfonyl imines using chromium (IV) dioxide as the oxidant....	04/30/2002
6306909	Anti-epileptogenic agents Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent ictogenesis and epileptogenesis. Methods for preparing the compounds of the invention...	10/23/2001
6306840	Cell adhesion inhibitors The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of us...	10/23/2001
6288116	Method of administration of a nutritional product to a person having renal failure L-arginine found essential to enhance the glomerular function of the kidneys is used to formulate a low viscosity, calorie-dense, nutritional product for a person having renal failure. In a product free of citric acid or citrates, for oral ingestion, the ...	09/11/2001
5623087	Method for preparation of optically active diarylalanines A method for preparing a diarylalanine compound is provided. The method includes reacting a diarylaminopropanediol with a reducing agent to form a diarylaminopropanol compound and/or contacting a serine ester derivative with an aryl metal reagent to form ...	04/22/1997
5530159	Preparation of ଱-alaninediacetic acid or its alkali metal or ammonium salts The invention relates to a process for preparing ଲ-alaninediacetic acid (Ia) or its alkali metal or ammonium salts (Ib) which comprises reacting iminodiacetic acid with acrylonitrile or C1 -C4 -alkyl acrylates in weakly acid to...	06/25/1996
5281749	Process for reducing the residual content of free alkylating agent in aqeous solutions of amphoteric or zwitterionic surfactants A process for reducing the residual content of free alkylating agent in aqueous solutions of amphoteric or zwitterionic surface-active agents by aftertreatment with ammonia, an amino acid containing 2 to 8 carbon atoms, or an oligopeptide....	01/25/1994
5200426	Inhibitors of neutral endopeptidase/CALLA as chemotherapeutic agents The present disclosure relates to inhibitors of neutral endopeptidase (NEP) which are proposed as novel agents for the treatment of CALLA+ positive cancers as well as other conditions such as hypertension....	04/06/1993
5152999	Liposome preparation The present invention relates to liposome preparations. In particular, the present invention relates to Adriamycin-entrapped liposome preparations comprising cholesterol derivatives having a negative charge as a liposome membrane constituent. Adriamycin-e...	10/06/1992
5026909	Method for preparing biologically active organic compound labelled with hydrogen isotope A method according to the invention comprises mixing the starting biologically active organic compound, an inorganic vehicle and a catalyst in the form of a platinum-group metal, followed by reacting the resulting mixture with an isotope of hydrogen at a ...	06/25/1991
4912228	Process of extraction of amino acids from aqueous solutions thereof An improvement in the process of extraction of amino acids from aqueous solutions in which the amino acids are extracted with quaternary ammonium extractants. A pretreatment of the amino acid containing aqueous solution with a tertiary amine prior to extr...	03/27/1990
4886889	Process for recovery of an amino acid from aqueous mixtures thereof Disclosed is a process for recovery of amino acids from aqueous mixtures. In particular, it relates to a treatment of said amino acid containing aqueous mixture prior to extraction of the amino acid with a water immiscible organic solution containing a wa...	12/12/1989
4886888	Extraction of amino an acid from aqueous mixtures thereof Amino acids can be purpified and/or concentrated by extracting aqueous mixtures such as fermentation broths by contacting an aqueous mixture containing amino acids with an organic solution containing a water insoluble extractant selected from the group co...	12/12/1989
4661606	Extraction of amino acids from aqueous mixtures and quaternary ammonium salt intermediates produced therein Amino acids can be purified and/or concentrated by extracting aqueous mixtures such as fermentation broths by contacting an aqueous mixture containing amino acids with an organic solution containing a water insoluble extractant....	04/28/1987
4585887	Process for the production of optically active 3-aminocarboxylic acid esters Process for the production of an optically active 3-aminocarboxylic acid ester from a ଲ-keto acid ester. The ଲ-keto acid ester is converted with a chiral amine into the corresponding enamine. The enamine is converted by hydrogenation in the pr...	04/29/1986
4371706	Preparation of alkali metal aminoalkanoates Alkali metal aminoalkanoate is prepared by contacting in the presence of an alkali metal carboxylate a reaction mixture in which there is at least one alkali metal hydroxide, at least one lactam, and water. Arylene sulfide polymer is prepared by contactin...	02/01/1983
4324886	Arylene sulfide polymer prepared from aminoalkanoate Alkali metal aminoalkanoate is prepared by contacting in the presence of an alkali metal carboxylate a reaction mixture in which there is at least one alkali metal hydroxide, at least one lactam, and water. Arylene sulfide polymer is prepared by contactin...	04/13/1982
4258210	Process for manufacturing sodium pantothenate A process for producing sodium pantothenate from ଲ-aminopropionitrile is disclosed....	03/24/1981
4234744	Process for the production of aminoacid hydrochlorides/or diaminoacid dihydrochlorides Aminoacid hydrochlorides or diaminoacid dihydrochlorides are produced by first reacting a halocarboxylic acid ester with an alkali metal cyanate in the presence of an alcohol to form the corresponding mono- or diurethane and then saponifying this to the c...	11/18/1980
4052451	Preparation of calcium pantothenate Beta-amino propionitrile is hydrolyzed with potassium hydroxide to produce potassium beta alanate, which, upon acidification produces free beta alanine with some potassium sulfate precipitate. The beta alanine solution with residual potassium sulfate is c...	10/04/1977
3935256	Process for the production of the calcium salt of pantothenic acid An improved process for the preparation of dl-calcium pantothenate is described wherein an anhydrous calcium salt of B-Alanine in methanolic solution is reacted with dl-pantolactone directly in a one-step process. The salt of B-Alanine is prepared by reac...	01/27/1976
3932501	Process for recovering beta-alanine from sodium chloride solutions ଲ-ALANINE IS RECOVERED FROM A STARTING SOLUTION OF SODIUM CHLORIDE AND ଲ-ALANINE BY: (A) EVAPORATING WATER FROM THE SOLUTION TO PRECIPITATE SODIUM CHLORIDE AND FORM A FIRST MOTHER LIQUOR; (B) SEPARATING THE FIRST MOTHER LIQUOR AND THE PRECIPIT...	01/13/1976

PatentStorm

Bizarre Patents

PatentStorm News

Class 562/576 - Beta alanine per se or salt thereof